Dr. Fokko de Haan (Solingen, Germany), working as a cardiologist in private practice, tells about his everyday problems with current oral anticoagulants. He finds the current VKAs “a weak case”, because of some disadvantages, like a narrow therapeutic window and the compliance.
Con’s of newer anticoagulant therapy are the lack of an antidote and a parameter to measure the effects.
|